Cathelicidins and defensins antimicrobial host defense peptides in the treatment of TB and HIV: Pharmacogenomic and nanomedicine approaches towards improved therapeutic outcomes

Tuberculosis (TB) and human immunodeficiency virus (HIV) represent a significant burden of disease on a global scale. Despite improvements in the global epidemic status, largely facilitated by increased access to pharmacotherapeutic interventions, slow progress in the development of new clinical int...

Descripción completa

Detalles Bibliográficos
Autores principales: Dlozi, Prince N., Gladchuk, Angelina, Crutchley, Rustin D., Keuler, Nicole, Coetzee, Renier, Dube, Admire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209695/
https://www.ncbi.nlm.nih.gov/pubmed/35676789
http://dx.doi.org/10.1016/j.biopha.2022.113189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209695/
https://www.ncbi.nlm.nih.gov/pubmed/35676789
http://dx.doi.org/10.1016/j.biopha.2022.113189

Ejemplares similares